Atlas Trials

The Effect of Dietary Management and Cysteine Supplementation on Growth Parameters and Biochemical Control for Pediatric Qatari Patients Affected with Classical B6 Non-responsive Homocystinuria.

Clinical trial NCT06622577 · UNKNOWN

Trial details

NCT number
NCT06622577
Sponsor
Hamad Medical Corporation
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Classical Homocystinuria
Start date
2024-12-01
Primary completion
2025-07-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.